Form 4: AdaptHealth Corp. Executive Albert Prast Reports Stock Transactions

Albert Prast, Chief Technology Officer of AdaptHealth Corp., reports the acquisition and disposition of common stock and derivative securities.

Summary

• On March 4, 2024, Albert Prast, Chief Technology Officer of AdaptHealth Corp., engaged in transactions involving the company's common stock.
• Prast acquired 135,443 shares of common stock at a price of $2.69.
• Simultaneously, Prast disposed of 135,443 shares at a weighted average price of $10.41, with individual sales ranging from $10.25 to $10.63.
• Following these transactions, Prast directly owns 181,083 shares of AdaptHealth Corp.
• Prast also exercised an employee stock option to acquire 135,443 shares of common stock at $2.69, which was granted on February 1, 2021, and expires on April 20, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies and are governed by SEC regulations.
• Form 4 filings are standard practice and ensure transparency in insider trading activities.
• Comparable companies like ResMed or Philips also have executives who regularly report their stock transactions.

Stakeholder Impact

• The transactions may influence investor perception of AdaptHealth Corp.'s stock.
• Transparency in executive stock transactions helps maintain investor confidence.

Key Dates